6794.TW

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$33M	+0.0%	$-1.98	$-1.98–$-1.98	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 1 of the last 4 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-02-25	$-0.49	$-0.49	+0.0%
2025-10-31	$-0.26	$-0.42	-61.5%
2025-02-21	$-0.45	$-0.46	-2.2%
2024-11-08	$-0.38	$-1.14	-200.0%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
6794.TWUnicoCell Biomed Co., Ltd.	$75.10	-1.83%	$4.8B	—
1295.TWOSynbio Tech Inc.	$44.55	-0.67%	$1.5B	—
3176.TWOMedigen Biotechnology Corp.	$37.85	-0.53%	$5.3B	—
3205.TWOSagittarius Life Science Corp	$46.30	-0.11%	$3.1B	—
6492.TWOSenhwa Biosciences, Inc.	$33.80

UnicoCell Biomed Co., Ltd.

UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.

www.unicocell.com

Employees: 27
IPO / List date: May 13, 2024
HQ: TW

Held by traders on TradeandTell

No one on the platform currently holds 6794.TW.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 6794.TW as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 6794.TW yet.